Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1565-1575
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

From JWH‐018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day
Rachael Andrews, Rita Jorge, Rachel Christie, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 4, pp. 378-387
Open Access | Times Cited: 36
Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo‐Pyridyl Synthetic Cannabinoid Receptor Agonist CH‐FUBBMPDORA
Marie H. Deventer, Maria Carmela Emanuele, Bernadette V. Stang, et al.
Drug Testing and Analysis (2025)
Open Access
A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB‐FUBIATA
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1639-1644
Open Access | Times Cited: 20
Evaluation of fentanyl immunoassay test strips for rapid in-situ detection of fentanyl and fentanyl analogs in seized samples and alternative matrices
Caitlyn Norman, Victoria Marland, Craig McKenzie, et al.
International Journal of Drug Policy (2023) Vol. 118, pp. 104102-104102
Open Access | Times Cited: 9
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists
Monica Patel, Xiaoxi Zheng, Luli R. Akinfiresoye, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176549-176549
Open Access | Times Cited: 3
SystematicIn VitroMetabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID
Shimpei Watanabe, Steven Baginski, Takahiro Iwai, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 5, pp. 455-463
Closed Access | Times Cited: 8
Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device
Gyles E. Cozier, Rachael Andrews, Anca Frinculescu, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 37, pp. 13829-13837
Open Access | Times Cited: 8
In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs
Marie H. Deventer, Mattias Persson, Caitlyn Norman, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 6, pp. 616-628
Closed Access | Times Cited: 8
Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists
Caitlyn Norman, Kristin Webling, O. А. Kyslychenko, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 9, pp. 915-935
Open Access | Times Cited: 7
Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection
Rachael Andrews, Benedict May, Federico J. Hernández, et al.
Analytical Chemistry (2023)
Open Access | Times Cited: 6
In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs
Marie H. Deventer, Caitlyn Norman, Robert L. Reid, et al.
Forensic Science International (2023) Vol. 343, pp. 111565-111565
Open Access | Times Cited: 5
Study of the Metabolic Profiles of “Indazole-3-Carboxamide” and “Isatin Acyl Hydrazone” (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS
Jiahong Xiang, Di Wen, Junbo Zhao, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 576-576
Open Access | Times Cited: 5
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA
Eric Sparkes, A. J. Timmerman, Jack Markham, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1787-1812
Closed Access | Times Cited: 1
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 469-469
Open Access | Times Cited: 4
In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH‐PIATA, a new indole‐3‐acetamide synthetic cannabinoid
Caitlyn Norman, Marie H. Deventer, Olivia Dremann, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 4, pp. 380-391
Open Access | Times Cited: 4
Interpreting mono- and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure
Liesl K. Janssens, Michaela J. Sommer, Katharina Elisabeth Grafinger, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3337-3350
Closed Access | Times Cited: 1
Waxy‐ or Putty‐Like Materials as a Novel Drug Preparation for Synthetic Cannabinoid Receptor Agonists: Detection in Prisons and In Vitro Cannabinoid Receptor Activity
A. J. Timmerman, Marie H. Deventer, Rachael Andrews, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 1
Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring
Keane Zhi Hao Lee, Ziteng Wang, Ching Yee Fong, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 11, pp. 1436-1448
Open Access | Times Cited: 7
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 7
Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA
Liesl K. Janssens, Adam Ametovski, Eric Sparkes, et al.
ACS Chemical Neuroscience (2022) Vol. 14, Iss. 1, pp. 35-52
Open Access | Times Cited: 6
Five cases of unintentional exposure to BZO-4en-POXIZID among nightclub attendees in New York City
Joseph J. Palamar, Marta Massano, Alberto Salomone
Journal of Analytical Toxicology (2023) Vol. 48, Iss. 1, pp. 75-80
Open Access | Times Cited: 3
A new synthetic cathinone: 3,4‐EtPV or 3,4‐Pr‐PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances
Benedikt Pulver, Jan Riedel, Folker Westphal, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 1, pp. 84-96
Open Access | Times Cited: 5
Aplicação da Toxicologia Analítica Verde no desenvolvimento de metodologias baseadas em LC-MS para detecção de Novas Substâncias Psicoativas em amostras biológicas
André Luis Fabris
(2024)
Open Access
Structure–Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA
Eric Sparkes, Callan J. Maloney, Jack Markham, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 11, pp. 2160-2181
Closed Access
In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references
Tobias Rautio, Robin Obrist, Lucas Krebs, et al.
Drug Testing and Analysis (2024)
Open Access
Page 1 - Next Page

Scroll to top